SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-047459
Filing Date
2023-02-24
Accepted
2023-02-24 07:00:53
Documents
1
Group Members
LSP V MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d164149dsc13da.htm SC 13D/A 50520
  Complete submission text file 0001193125-23-047459.txt   52124
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88651 | Film No.: 23662310
SIC: 2834 Pharmaceutical Preparations

Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV
Business Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV 31-20-664-5500
LSP V Cooperatieve U.A. (Filed by) CIK: 0001726006 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7
Type: SC 13D/A